Gastrin I, human

CAS No. 10047-33-3

Gastrin I, human( —— )

Catalog No. M25047 CAS No. 10047-33-3

Gastrin I, human is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 383 In Stock
10MG 601 In Stock
25MG 1017 In Stock
50MG 1368 In Stock
100MG 1782 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Gastrin I, human
  • Note
    Research use only, not for human use.
  • Brief Description
    Gastrin I, human is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.
  • Description
    Gastrin I, human is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Cholecystokinin Receptor
  • Recptor
    DNA/RNA Synthesis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10047-33-3
  • Formula Weight
    2098.2
  • Molecular Formula
    C97H124N20O31S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL (23.83 mM; Need ultrasonic);NH4OH : 50 mg/mL (23.83 mM; ultrasonic and adjust pH to 11 with NH3·H2O)
  • SMILES
    [pE-GPWLEEEEEAYGWMDF-NH2]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Noble F, et al. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev. 1999 Dec;51(4):745-81. [Content Brief] 2. Blandizzi C, et al. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion. Eur J Pharmacol. 1999 May 28;373(1):71-84. [Content Brief]
molnova catalog
related products
  • PF-04756956

    A potent, selective CCK1 receptor agonist with EC50 of 0.47 nM; elicits no biological response at the CCK2 receptors.

  • GI 181771

    GI 181771 is an agonist of the cholecystokinin 1 receptor. GI 181771 can be used in studies about obesity.

  • Lorglumide sodium sa...

    Lorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.